FDA NDC Directory · JSON-LD · Markdown

Eysuvis

NDC 71571-333 · HUMAN PRESCRIPTION DRUG · SUSPENSION/ DROPS

Generic nameloteprednol etabonate
Labeler / ManufacturerALCON LABORATORIES, INC.
Marketing categoryNew Drug Application (innovator) · App NDA210933
Dosage form / routeSUSPENSION/ DROPS · OPHTHALMIC
Active ingredientsLOTEPREDNOL ETABONATE (2.5 mg/mL)
Marketing started20201118
Package count3

External sources

Source: openFDA. Public-domain (CC0).